Table 4.
MR effect of COVID-19 hospitalization on dyslipidemia.
| Exposure | Outcome | Beta | P |
|---|---|---|---|
| COVID-19 hospitalization | Hyperlipidaemia | −0.069 | 0.299 |
| COVID-19 hospitalization | apolipoprotein A | 0.013 | 0.301 |
| COVID-19 hospitalization | apolipoprotein B | 0.008 | 0.621 |
| COVID-19 hospitalization | HDL cholesterol | 0.005 | 0.609 |
| COVID-19 hospitalization | triglycerides | −0.004 | 0.716 |
| COVID-19 hospitalization | LDL cholesterol | 0.012 | 0.564 |
| COVID-19 hospitalization | Ratio of apolipoprotein B to apolipoprotein A1 | 0.015 | 0.502 |
| COVID-19 hospitalization | Total cholesterol | 0.014 | 0.52 |
| COVID-19 hospitalization | VLDL cholesterol | 0.018 | 0.454 |
| COVID-19 hospitalization | Lipoprotein A | −0.492 | 0.096 |
Note: Beta is the influence that exposure inflicts on the outcome, the higher the value the stronger the influence.